Patients

Being treated in a Comprehensive Cancer Center

Find out more about us

Healthcare professionals

Research and UNICANCER patient management

Your page

Find a Center

Retrouvez les Centres de lutte contre le cancer sur l'ensemble du territoire

 

The tumour bank

The R&D UNICANCER plasma and tumour banks are essential elements for translational research that will soon be centralised at the Léon Bérard Center in Lyon.

 

 

Tumour banks

These banks contain tumour samples and provide essential study material for translational research. This kind of research ensures the research-patient care continuum and the rapid application of innovative techniques directly to patients. This is why all of the studies sponsored by R&D UNICANCER must prepare a tumour and/or blood bank – with patient consent – for translational research programmes.
The goal: carry out specific research on these tumours, for example, researching the genes prone to giving rise to cancers or molecular anomalies that cause treatment resistance.
Existing banks currently contain nearly 3,000 tumours in paraffin and more than 1,000 frozen tumours.

Centralise UNICANCER R&D biological specimens

These banks are currently housed in several French Comprehensive Cancer Centres.
In 2010, R&D UNICANCER wished to centralise all of the tumour and plasma banks. The goal of a tumour bank located at a single site is to ensure traceability, centralisation and labelling of samples from all studies sponsored by R&D UNICANCER.
The Léon Bérard Center (Lyon) will house the R&D UNICANCER tumour bank.
The R&D UNICANCER tumour bank will be made available to researchers carrying out projects deemed interesting by the UNICANCER Group.

For further information, please contact us.